Why Emergent BioSolutions Stock Soared 47% in the First Half of 2020
Shares of biopharmaceutical company Emergent BioSolutions (NYSE: EBS) gained 46.6% in the first half of 2020 (January to June), according to data from S&P Global Market Intelligence. The S&P 500 returned negative 3.1% over the period.
In 2020, the stock is up 55.9% through Thursday, July 2, while the S&P 500 has returned negative 2.1%.
Image source: Getty Images.
Source Fool.com
